The pathophysiology of migraine: year 2005
- PMID: 16355290
- PMCID: PMC3451639
- DOI: 10.1007/s10194-005-0165-2
The pathophysiology of migraine: year 2005
Abstract
Migraine is a complex patholophysiology in which both central and peripheral components of the trigeminal pain pathway probably play a significant role, both in the symptoms and signs of the attack and in the mechanisms of action of antimigraine compounds, such as triptans, which constitute the most important therapy for aborting migraine pain and possess several mechanisms on 5-HT receptor-mediated actions. The experimental neurogenic inflammation model represents a simple procedure to obtain preliminary information on well characterized receptortargeted drugs. The apparent paradox observed with certain drugs that are shown to be effective in this model but not in clinical trials offers the opportunity to better manipulate structure-activity to obtain the best pharmacological profile using an array of experimental models. The observation that nitric oxide donors induce migraine-like pain in migraineours and that nitric oxide plays a pivotal role in the control of several functions in the central nervous system, has prompted the use of such molecules for better understanding the pathophysiology of migraine attacks. A link between central and peripheral components of the trigeminal pain pathway is provided by the observation that cortical spreading depression in the rat activates trigeminovascular afferents and induces a series of cortical meningeal and brainstem events consistent with the development of headache. Studies in humans support the hypothesis that cortical spreading depression underlies migraine.aura. Therefore, tt is possible that visual, motor or sensory aura might be responsible for the generation of the pain through the above mechanisms.
Similar articles
-
Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.Pain. 2013 Dec;154 Suppl 1:S44-53. doi: 10.1016/j.pain.2013.07.021. Epub 2013 Jul 25. Pain. 2013. PMID: 23891892 Review.
-
Peripheral and central activation of trigeminal pain pathways in migraine: data from experimental animal models.Cephalalgia. 2003;23 Suppl 1:1-4. doi: 10.1046/j.1468-2982.23.s1.1.x. Cephalalgia. 2003. PMID: 12699454 Review.
-
From spreading depression to the trigeminovascular system.Neurol Sci. 2006 May;27 Suppl 2:S86-90. doi: 10.1007/s10072-006-0577-z. Neurol Sci. 2006. PMID: 16688636 Review.
-
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.Nat Med. 2002 Feb;8(2):136-42. doi: 10.1038/nm0202-136. Nat Med. 2002. PMID: 11821897
-
[Pathophysiology of migraine and clinical implications].Schmerz. 2008 Oct;22(5):523-6, 528-30. doi: 10.1007/s00482-008-0693-1. Schmerz. 2008. PMID: 18600349 Review. German.
Cited by
-
Stroke and migraine.Curr Cardiol Rep. 2007 Mar;9(1):13-9. doi: 10.1007/s11886-007-0004-y. Curr Cardiol Rep. 2007. PMID: 17362679 Review.
-
Patent foramen ovale and migraine: association, causation, and implications of clinical trials.Curr Pain Headache Rep. 2009 Jun;13(3):221-6. doi: 10.1007/s11916-009-0037-6. Curr Pain Headache Rep. 2009. PMID: 19457283 Review.
-
The childhood migraine syndrome.Nat Rev Neurol. 2021 Jul;17(7):449-458. doi: 10.1038/s41582-021-00497-6. Epub 2021 May 26. Nat Rev Neurol. 2021. PMID: 34040231 Review.
-
Stroke and migraine.Curr Treat Options Cardiovasc Med. 2008 Jun;10(3):253-60. doi: 10.1007/s11936-008-0027-8. Curr Treat Options Cardiovasc Med. 2008. PMID: 18582414
-
Vestibular-evoked myogenic potentials in vestibular migraine.J Neurol. 2009 Sep;256(9):1447-54. doi: 10.1007/s00415-009-5132-4. Epub 2009 Apr 18. J Neurol. 2009. PMID: 19377861
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous